Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Change in Acquisitions & Divestments: 2014-2024

Historic Change in Acquisitions & Divestments for Astria Therapeutics (ATXS) over the last 10 years, with Dec 2024 value amounting to $4.1 billion.

  • Astria Therapeutics' Change in Acquisitions & Divestments fell 11.65% to $28.4 million in Q4 2019 from the same period last year, while for Dec 2019 it was $151.1 million, marking a year-over-year change of. This contributed to the annual value of $4.1 billion for FY2024, which is 96.80% up from last year.
  • Latest data reveals that Astria Therapeutics reported Change in Acquisitions & Divestments of $4.1 billion as of FY2024, which was up 96.80% from $2.1 billion recorded in FY2023.
  • In the past 5 years, Astria Therapeutics' Change in Acquisitions & Divestments ranged from a high of $4.1 billion in FY2024 and a low of $59.0 million during FY2021.
  • In the last 3 years, Astria Therapeutics' Change in Acquisitions & Divestments had a median value of $2.1 billion in 2023 and averaged $2.1 billion.
  • In the last 5 years, Astria Therapeutics' Change in Acquisitions & Divestments crashed by 54.27% in 2020 and then skyrocketed by 799.24% in 2023.
  • Astria Therapeutics' Change in Acquisitions & Divestments (Yearly) stood at $69.1 million in 2020, then decreased by 14.63% to $59.0 million in 2021, then surged by 288.18% to $229.0 million in 2022, then soared by 799.24% to $2.1 billion in 2023, then spiked by 96.80% to $4.1 billion in 2024.